Distribution of bed days by HIV status and reason for admission.

<p>Distribution of bed days by HIV status and reason for admission.</p

Summary of reasons for admission by HIV status.

<p>This figure presents the top 5 reasons for admission for each HIV status category. All other reasons were collapsed into the other category.* Tuberculosis was the most prevalent reason for admission amongst HIV-positive admissions accounting for 35%. CVD was the single most prevalent reason for admission amongst HIV-negative admissions accounting for 17%, while it only accounted for 4% of all HIV-positive admissions.</p

Baseline characteristics of admission cohort.

<p>Baseline characteristics of admission cohort.</p

Cost for HIV-positive admissions (HIV-positive only), by cost category in United States Dollars (USD).

<p>Cost for HIV-positive admissions (HIV-positive only), by cost category in United States Dollars (USD).</p

Box and whisker plot of CD4 count by reason for admission.

<p>The distribution of CD4 count at admission shows that all HIV positive admissions with one exception had a median CD4 count below 500 cells/mm³. This suggests that boosting the CD4 count of HIV positive patients by starting treatment early and ensuring adherence while on treatment may reduce the frequency and severity of admission.</p

Baseline characteristics at HIV treatment initiation.

<p>Baseline characteristics at HIV treatment initiation.</p

Mean 12 month cost per patient (USD) by outcome and facility, broken down by cost category.

<p>Mean 12 month cost per patient (USD) by outcome and facility, broken down by cost category.</p

Outcomes at 12 months after ART initiation with relative risk.

<p>Outcomes at 12 months after ART initiation with relative risk.</p

Time in care (months) and resource utilization for study period by outcome and facility.

<p>Time in care (months) and resource utilization for study period by outcome and facility.</p

Methods for estimating costs.

<p>Methods for estimating costs.</p